Literature DB >> 29081245

Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?

Brady E Beltran1, Pilar Quiñones2, Gadwyn Sanchez3, Antonio Paredes3, Celia Moises3, Esther Cotrina4, Carlos A Torres-Cabala5, Roberto N Miranda6, Jorge J Castillo7.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29081245     DOI： 10.1080/10428194.2017.1393666

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  2 in total

Review 1.  Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review.

Authors:  Hirotaka Mori; Masahiko Fukatsu; Hiroshi Ohkawara; Yuka Oka; Yuki Kataoka; Shunsuke Taito; Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2021-08-30       Impact factor: 2.490

2.  Immunosuppression-associated primary cutaneous plasmablastic lymphoma secondary to romidepsin.

Authors:  Collin M Costello; Connor J Maly; Sam Snider; Kevin J Severson; David J DiCaudo; Allison C Rosenthal; Donald W Northfelt; William Rule; Fiona E Craig; Mark R Pittelkow; Aaron R Mangold
Journal:  JAAD Case Rep       Date:  2019-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.